V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017877 | 270008495 | 0 | 71 | Curative (C) | 2016-11-05 | 2016-12-25 | COPP + Dacarbazine | 2 | null | 270012948 | COPP + DACARBAZINE |
| 270017878 | 270008497 | 1.68 | null | Curative (C) | 2015-04-12 | 2015-05-09 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012949 | TRIAL |
| 270017879 | 270008500 | 1.8 | 41.85 | null | null | 2015-04-17 | BEACOPP | N | N | 270012955 | BEACOPP |
| 270017880 | 270016682 | 1.74 | 16.4 | Curative (C) | 2016-01-29 | 2017-12-22 | CETUXIMAB | N | N | 270012966 | CETUXIMAB |
| 270017881 | 270008503 | 1.58 | 72.9 | Palliative (P) | 2014-10-09 | 2014-10-20 | CETUXIMAB | N | N | 270012975 | CETUXIMAB |
| 270017882 | 270008511 | 0 | null | Curative (C) | 2015-01-12 | 2015-02-08 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270013017 | TRIAL |
| 270017883 | 270008511 | null | 70.6 | null | 2014-09-12 | 2015-08-31 | Cetuximab 14 day | N | N | 270013017 | CETUXIMAB |
| 270017884 | 270008517 | 1.78 | 86 | Curative (C) | 2017-11-11 | 2018-01-31 | BEACOPP-14 | N | N | 270013029 | BEACOPP |
| 270017885 | 270008523 | 1.62 | 73.2 | Palliative (P) | 2014-08-28 | 2014-09-26 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270013072 | CETUXIMAB |
| 270017886 | 270008530 | 1.89 | 130.2 | Curative (C) | 2014-01-26 | 2014-01-30 | COPP + Dacarbazine | N | N | 270013128 | COPP + DACARBAZINE |
| 270017887 | 270008535 | 1.8 | 74 | Palliative (P) | 2014-01-12 | 2014-01-19 | CETUXIMAB | 02 | N | 270013143 | CETUXIMAB |
| 270017888 | 270008538 | null | null | Palliative (P) | 2017-03-05 | 2017-05-18 | Cetuximab 7 day (Cycle 1) | N | N | 270013148 | CETUXIMAB |
| 270017889 | 270008541 | 1.74 | 59.6 | Adjuvant (A) | null | 2016-05-21 | CETUXIMAB | 2 | N | 270013162 | CETUXIMAB |
| 270017890 | 270008543 | null | 98.2 | Adjuvant (A) | null | 2014-05-07 | COPP + Dacarbazine | N | N | 270013164 | COPP + DACARBAZINE |
| 270017891 | 270016693 | null | null | null | 2013-12-16 | 2013-12-16 | BEACOPP-14 | N | N | 270013165 | BEACOPP |
| 270017892 | 270008548 | 1.72 | 58.4 | Neo-adjuvant (N) | 2017-01-30 | 2017-01-31 | COPP + Dacarbazine | N | N | 270013196 | COPP + DACARBAZINE |
| 270017893 | 270019108 | 1.7 | null | Curative (C) | 2012-10-19 | 2015-08-19 | CETUXIMAB | N | N | 270013221 | CETUXIMAB |
| 270017894 | 270008557 | 1.66 | null | null | 2013-06-21 | 2013-06-21 | COPP + Dacarbazine | N | null | 270013224 | COPP + DACARBAZINE |
| 270017895 | 270008559 | 1.7 | 102 | Curative (C) | 2016-11-25 | 2016-11-25 | Cetuximab 14 day | N | N | 270013228 | CETUXIMAB |
| 270017896 | 270008566 | 1.57 | 83 | Curative (C) | 2018-08-29 | 2018-09-12 | Escalated BEACOPP | N | N | 270013267 | BEACOPP |
| 270017897 | 270008568 | null | 88 | Curative (C) | 2017-09-18 | 2017-09-25 | Cetuximab 14 day | 99 | N | 270013279 | CETUXIMAB |
| 270017898 | 270008575 | 1.99 | 62 | Curative (C) | 2017-06-23 | 2017-07-08 | HD EuroNet-PHL-C1 COPDAC | 02 | Y | 270013318 | TRIAL |
| 270017899 | 270008577 | 0 | 77 | Adjuvant (A) | 2014-04-21 | 2014-04-21 | COPP + Dacarbazine | N | N | 270013336 | COPP + DACARBAZINE |
| 270017900 | 270008580 | 1.68 | 71 | Disease modification (D) | 2016-07-25 | 2016-10-19 | BEACOPP-14 | 02 | N | 270013349 | BEACOPP |
| 270017901 | 270014056 | 1.62 | 57.3 | Curative (C) | 2014-02-03 | 2014-02-08 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013353 | TRIAL |
| 270017902 | 270008584 | 1.57 | null | Curative (C) | 2014-07-17 | 2014-08-28 | Cetuximab 7 day (>Cycle 2) | null | null | 270013366 | CETUXIMAB |
| 270017903 | 270008587 | 1.83 | 57.6 | Curative (C) | 2017-10-29 | 2017-10-30 | Cetuximab 7 day (Cycle 1) | null | Y | 270013367 | CETUXIMAB |
| 270017904 | 270008589 | 1.73 | null | Palliative (P) | 2015-07-10 | 2015-07-12 | CETUXIMAB | N | N | 270013382 | CETUXIMAB |
| 270017905 | 270008593 | 1.79 | 77 | null | 2014-12-15 | 2014-12-15 | BEACOPP-14 | 02 | null | 270013387 | BEACOPP |
| 270017906 | 270008599 | 1.68 | null | Curative (C) | 2016-09-17 | 2016-10-03 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270013405 | TRIAL |
| 270017907 | 270014063 | 0 | 55.1 | Curative (C) | 2016-10-12 | 2016-12-07 | COPP + Dacarbazine | N | N | 270013410 | COPP + DACARBAZINE |
| 270017908 | 270016704 | null | 40.4 | Curative (C) | null | 2017-10-09 | CETUXIMAB | N | N | 270013475 | CETUXIMAB |
| 270017909 | 270008610 | 0 | 64 | Curative (C) | 2018-04-19 | 2018-04-19 | COPP + Dacarbazine | null | N | 270013478 | COPP + DACARBAZINE |
| 270017910 | 270008611 | 1.85 | 34 | Curative (C) | 2015-10-07 | 2016-05-18 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013483 | TRIAL |
| 270017911 | 270008613 | 0 | 75.7 | Curative (C) | 2014-03-11 | 2014-03-13 | COPP + Dacarbazine | 02 | null | 270013488 | COPP + DACARBAZINE |
| 270017912 | 270008616 | 1.79 | 41.7 | Curative (C) | 2013-09-30 | 2013-10-06 | Escalated BEACOPP | N | N | 270013508 | BEACOPP |
| 270017913 | 270008619 | 1.81 | 43 | Curative (C) | 2014-04-15 | 2014-06-17 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013509 | TRIAL |
| 270017914 | 270008623 | 1.57 | 31 | null | 2014-08-19 | 2014-08-19 | BEACOPP | null | null | 270013510 | BEACOPP |
| 270017915 | 270014072 | null | null | Palliative (P) | 2016-01-22 | 2016-10-02 | CETUXIMAB | 2 | N | 270013529 | CETUXIMAB |
| 270017916 | 270008626 | 0 | 46.8 | Curative (C) | 2014-03-10 | 2014-05-14 | COPP + Dacarbazine | N | N | 270013544 | COPP + DACARBAZINE |
| 270017917 | 270008630 | 1.69 | 88.3 | Curative (C) | 2016-10-16 | 2017-01-23 | Trial Unspecified | 2 | N | 270013568 | TRIAL |
| 270017918 | 270008632 | 1.29 | 25 | Curative (C) | 2015-08-15 | 2015-11-15 | COPP + Dacarbazine | null | null | 270013576 | COPP + DACARBAZINE |
| 270017919 | 270008633 | 0 | 47.2 | null | 2015-11-14 | 2015-11-18 | COPP + Dacarbazine | N | null | 270013582 | COPP + DACARBAZINE |
| 270017920 | 270016711 | 1.85 | 51 | Curative (C) | 2013-07-24 | 2013-07-24 | Trial Unspecified | N | N | 270013582 | TRIAL |
| 270017921 | 270008635 | 1.75 | 94.7 | Curative (C) | 2017-06-30 | 2017-07-01 | HD EuroNet-PHL-C1 COPDAC | 01 | null | 270013590 | TRIAL |
| 270017922 | 270014080 | 1.64 | 65.85 | Curative (C) | 2016-08-18 | 2016-08-19 | Escalated BEACOPP | 02 | N | 270013636 | BEACOPP |
| 270017923 | 270020052 | 1.8 | 42.3 | Not known (9) | 2017-05-30 | 2017-06-22 | Cetuximab 7 day (>Cycle 2) | N | N | 270013711 | CETUXIMAB |
| 270017924 | 270014083 | 1.86 | 99 | Adjuvant (A) | 2012-09-14 | 2013-05-23 | CETUXIMAB | N | N | 270013731 | CETUXIMAB |
| 270017925 | 270008646 | 0 | 79.3 | Curative (C) | 2017-10-28 | 2017-10-31 | Trial Unspecified | N | null | 270013753 | TRIAL |
| 270017926 | 270008650 | 1.8 | 54.6 | Palliative (P) | 2015-10-10 | 2015-10-12 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013762 | TRIAL |